Riverbridge Partners’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.8M Sell
436,507
-172,409
-28% -$9.31M 0.86% 40
2026
Q1
$31.8M Sell
608,916
-176,872
-23% -$10.6M 0.78% 44
2025
Q4
$46.2M Sell
785,788
-120,654
-13% -$7.33M 0.87% 42
2025
Q3
$50.4M Sell
906,442
-48,447
-5% -$2.6M 0.85% 39
2025
Q2
$49.1M Buy
954,889
+334,436
+54% +$16.8M 0.79% 44
2025
Q1
$36.4M Sell
620,453
-66,269
-10% -$4.49M 0.58% 61
2024
Q4
$49.5M Sell
686,722
-50,927
-7% -$3.74M 0.68% 54
2024
Q3
$59M Sell
737,649
-89,438
-11% -$6.72M 0.79% 48
2024
Q2
$59.3M Sell
827,087
-34,544
-4% -$2.54M 0.81% 48
2024
Q1
$60.7M Sell
861,631
-5,568
-0.6% -$398K 0.74% 53
2023
Q4
$66.9M Sell
867,199
-15,058
-2% -$992K 0.84% 45
2023
Q3
$60.1M Sell
882,257
-20,523
-2% -$1.62M 0.82% 44
2023
Q2
$73.7M Buy
902,780
+90,066
+11% +$7.24M 0.93% 41
2023
Q1
$60.3M Sell
812,714
-12,707
-2% -$979K 0.85% 45
2022
Q4
$68.4M Sell
825,421
-49,055
-6% -$3.9M 1.03% 32
2022
Q3
$62.1M Buy
874,476
+155,220
+22% +$13.4M 0.92% 39
2022
Q2
$62.3M Sell
719,256
-206,876
-22% -$19.4M 1% 36
2022
Q1
$100M Sell
926,132
-11,424
-1% -$1.18M 1.13% 27
2021
Q4
$121M Buy
937,556
+23,488
+3% +$2.88M 1.2% 27
2021
Q3
$111M Buy
914,068
+4,320
+0.5% +$526K 1.11% 35
2021
Q2
$102M Buy
909,748
+48,496
+6% +$5.1M 1.04% 32
2021
Q1
$82.2M Sell
861,252
-874,696
-50% -$79.8M 0.94% 40
2020
Q4
$138M Buy
1,735,948
+133,940
+8% +$9.7M 1.52% 23
2020
Q3
$99.2M Buy
1,602,008
+52,012
+3% +$3.38M 1.38% 25
2020
Q2
$102M Buy
1,549,996
+10,744
+0.7% +$643K 1.61% 24
2020
Q1
$73M Sell
1,539,252
-12,180
-0.8% -$609K 1.53% 26
2019
Q4
$85.1M Sell
1,551,432
-35,924
-2% -$1.88M 1.53% 23
2019
Q3
$77.6M Sell
1,587,356
-6,944
-0.4% -$348K 1.47% 26
2019
Q2
$83.1M Sell
1,594,300
-103,084
-6% -$5.19M 1.57% 23
2019
Q1
$84.3M Sell
1,697,384
-205,040
-11% -$9.23M 1.64% 20
2018
Q4
$68.8M Sell
1,902,424
-81,912
-4% -$3.42M 1.44% 24
2018
Q3
$101M Sell
1,984,336
-79,116
-4% -$3.5M 1.69% 15
2018
Q2
$76.3M Sell
2,063,452
-58,004
-3% -$2.21M 1.38% 26
2018
Q1
$80.1M Buy
2,121,456
+10,608
+0.5% +$375K 1.46% 22
2017
Q4
$68.4M Sell
2,110,848
-71,036
-3% -$2.26M 1.32% 26
2017
Q3
$65.9M Sell
2,181,884
-160,184
-7% -$4.75M 1.3% 24
2017
Q2
$68.8M Sell
2,342,068
-77,120
-3% -$2.11M 1.32% 25
2017
Q1
$61.5M Sell
2,419,188
-117,548
-5% -$3.03M 1.23% 31
2016
Q4
$65.2M Sell
2,536,736
-203,460
-7% -$5.35M 1.36% 21
2016
Q3
$75M Sell
2,740,196
-54,704
-2% -$1.5M 1.5% 24
2016
Q2
$78.8M Sell
2,794,900
-91,732
-3% -$2.36M 1.63% 17
2016
Q1
$68.2M Buy
2,886,632
+17,764
+0.6% +$391K 1.42% 26
2015
Q4
$64.5M Sell
2,868,868
-126,224
-4% -$2.88M 1.33% 27
2015
Q3
$69.2M Sell
2,995,092
-93,816
-3% -$2.35M 1.43% 26
2015
Q2
$76M Sell
3,088,908
-248,932
-7% -$6.22M 1.43% 27
2015
Q1
$83.7M Buy
3,337,840
+36,856
+1% +$876K 1.51% 27
2014
Q4
$76.3M Sell
3,300,984
-122,008
-4% -$2.79M 1.42% 27
2014
Q3
$80.1M Sell
3,422,992
-257,092
-7% -$6.03M 1.56% 25
2014
Q2
$85.2M Buy
3,680,084
+63,908
+2% +$1.41M 1.48% 26
2014
Q1
$77.2M Sell
3,616,176
-893,820
-20% -$20.1M 1.4% 28
2013
Q4
$107M Buy
4,509,996
+177,252
+4% +$3.84M 1.94% 19
2013
Q3
$86.7M Buy
4,332,744
+44,124
+1% +$837K 1.88% 20
2013
Q2
$74.1M Buy
+4,288,620
New +$71.2M 1.85% 23

Other funds holding TECH

Riverbridge Partners's TECH Position: Q2 2026 in Review

Riverbridge Partners reduced its Bio-Techne (TECH) stake by 28% in Q2 2026, selling an estimated $9.31M and leaving 436,507 shares worth $30.8M. The position accounts for 0.86% of the portfolio, ranked #40.

Riverbridge Partners first reported a position in TECH in Q2 2013 and has held it in 53 quarters since. The position peaked at $138M in Q4 2020. 170 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Riverbridge Partners held 436,507 shares of Bio-Techne worth $30.8M as of Q2 2026.
  • Riverbridge Partners sold 172,409 Bio-Techne shares in Q2 2026, an estimated $9.31M.
  • Bio-Techne made up 0.86% of Riverbridge Partners's portfolio in Q2 2026, its #40 holding.
  • Riverbridge Partners first reported a position in Bio-Techne in Q2 2013 and has held it in 53 quarters since.
  • Riverbridge Partners's Bio-Techne position peaked at $138M in Q4 2020.
  • 170 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Riverbridge Partners's 13F filing for Q2 2026, filed 13 Jul 2026.